High-throughput sequencing of archival cerebrospinal fluid specimens defines B-lymphoblastic leukemia clonal composition

被引:0
|
作者
Foley, Karl [1 ]
Adlowitz, Diana G. [2 ,3 ]
Baker, Cameron [4 ]
Rock, Philip J. [3 ]
Burack, Richard [3 ]
Fries, Carol [2 ,3 ]
机构
[1] Univ Rochester, Sch Med & Dent, Rochester, NY USA
[2] Univ Rochester, Dept Pediat, Div Pediat Hematol & Oncol, Rochester, NY USA
[3] Univ Rochester, Dept Pathol & Lab Med, Rochester, NY USA
[4] Univ Rochester, Genom Res Ctr, Dept Biostat & Computat Biol, Rochester, NY USA
关键词
B-lymphoblastic leukemia; clonal composition; CNS involvement; CSF surveillance; immunoglobulin high-throughput sequencing; pediatric oncology; relapse prediction; response assessment; CENTRAL-NERVOUS-SYSTEM; DISEASE DETECTION; DIAGNOSIS; CHILDREN; RISK;
D O I
10.1002/pbc.31281
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Detailed characterization of the B-lymphoblastic leukemia (B-ALL) cells which invade the central nervous system (CNS) has been limited by practical challenges. To test whether the clonal composition of the cerebrospinal fluid (CSF) reflects the primary B-ALL tissue, we applied immunoglobulin (Ig) high-throughput sequencing (HTS) of archival CSF cytospin preparations from six patients with morphologically defined CNS involvement. We discovered that most CSF clones are detectable at some timepoint in the primary tissue, but that shifting clonal abundance is prevalent across tissue sites between diagnosis and relapse. Ig HTS of CSF cytospins may improve understanding of sanctuary site dissemination in B-ALL.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Retrospective Analysis of Minimal Residual Disease Testing By High Throughput Immunosequencing Versus High Sensitivity Flow Cytometry and qPCR in B-Lymphoblastic Leukemia
    Fathalla, Omar
    Khan, Anwar
    Pakasticali, Nagehan
    Shah, Bijal D.
    Hussaini, Mohammad O.
    BLOOD, 2021, 138
  • [22] High-throughput sequencing of cerebrospinal fluid for diagnosis of chronic Propionibacterium acnes meningitis in an allogeneic stem cell transplant recipient
    Wylie, K. M.
    Blanco-Guzman, M.
    Wylie, T. N.
    Lawrence, S. J.
    Ghobadi, A.
    DiPersio, J. F.
    Storch, G. A.
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (02) : 227 - 233
  • [23] A Comparative Analysis of the Immunoglobulin Repertoire in Leukemia Cells and B Cells in Chinese Acute Myeloid Leukemia by High-Throughput Sequencing
    Yan, Huige
    Wu, Lina
    Wang, Pingzhang
    Xia, Miaoran
    Shi, Zhan
    Huang, Xinmei
    Yin, Sha
    Jiang, Qian
    Yin, C. Cameron
    Zhao, Xiangyu
    Qiu, Xiaoyan
    BIOLOGY-BASEL, 2024, 13 (08):
  • [24] Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?
    Levy, Gabriel
    Kicinski, Michal
    van der Straeten, Jona
    Uyttebroeck, Anne
    Ferster, Alina
    De Moerloose, Barbara
    Dresse, Marie-Francoise
    Chantrain, Christophe
    Brichard, Benedicte
    Bakkus, Marleen
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [25] Minimal Residual Disease Detection Using High-Throughput Sequencing Predicts Clinical Outcome in Patients with Pediatric B-Lineage Acute Lymphoblastic Leukemia
    Harris, Marian
    Neuberg, Donna S.
    Zheng, Jianbiao
    Faham, Malek
    Sallan, Stephen E.
    Silverman, Lewis B.
    BLOOD, 2014, 124 (21)
  • [26] Multiple sclerosis: high-throughput T-cell receptor sequencing reveals clonal expansions of Epstein-Barr virus specific T-cells in the cerebrospinal fluid
    Lossius, A.
    Johansen, J.
    Vartdal, F.
    Robins, H.
    Holmoy, T.
    Olweus, J.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 133 - 134
  • [27] ULTRA-DEEP SEQUENCING DEMONSTRATES VARYING CLONAL COMPOSITION BETWEEN DISEASE SITES IN B CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B ALL)
    Simpson, Carol Fries
    Adlowitz, Diana
    Spence, Janice
    Spence, John
    Rock, Philip
    Burack, W. Richard
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [28] High-Throughput Sequencing of T-Cell Receptor Gene Loci for Minimal Residual Disease Monitoring in T Lymphoblastic Leukemia
    Wu, David
    Sherwood, Anna
    Winter, Stuart S.
    Dunsmore, Kimberly
    Loh, Mignon L.
    Fromm, Jonathan R.
    Greisman, Harvey A.
    Sabath, Daniel E.
    Wood, Brent L.
    Robins, Harlan
    BLOOD, 2011, 118 (21) : 1092 - 1092
  • [29] Minimal Residual Disease Monitoring of Acute Lymphoblastic Leukemia by High-Throughput Sequencing of the Peripheral Blood: Case Examples and Literature Review
    Muffly, Lori
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S53 - S55
  • [30] High-throughput sequencing of peripheral blood for minimal residual disease monitoring in childhood precursor B-cell acute lymphoblastic leukemia: A prospective feasibility study
    Bartram, Jack
    Wright, Gary
    Adams, Stuart
    Archer, Paul
    Brooks, Tony
    Edwards, Darren
    Hancock, Jerry
    Knecht, Henrik
    Inglott, Sarah
    Mountjoy, Edward
    Roynane, Marie
    Wakeman, Stephanie
    Moppett, John
    Hubank, Mike
    Goulden, Nick
    PEDIATRIC BLOOD & CANCER, 2022, 69 (03)